outbreak
sever
acut
respiratori
syndrom
sar
result
death
patient
affect
mild
pulmonari
symptom
success
recov
object
present
work
identifi
use
sar
coronaviru
sarscov
mous
infect
model
immun
factor
respons
clear
viru
elimin
pulmonari
sarscov
infect
requir
activ
b
cell
cell
furthermor
passiv
immun
postinfect
homolog
murin
antisarscov
antiserum
show
greater
elimin
efficaci
sarscov
heterolog
rabbit
antiserum
despit
use
equival
titer
neutral
antibodi
distinct
mediat
mous
phagocyt
cell
monocytederiv
infiltr
macrophag
partial
alveolar
macrophag
neutrophil
demonstr
adopt
transfer
donor
immunolog
deplet
select
cell
type
result
indic
cooper
antisarscov
antibodi
phagocyt
cell
play
import
role
elimin
sarscov
novemb
juli
world
suffer
global
outbreak
sever
acut
respiratori
syndrom
sar
diseas
result
case
death
caus
novel
type
coronaviru
term
sarscov
http
wwwwhointcsrsar
patient
sar
usual
develop
high
fever
follow
clinic
symptom
lower
respiratori
tract
diseas
sever
case
patient
present
acut
respiratori
distress
syndrom
character
diffus
alveolar
damag
ultim
die
peiri
et
al
peiri
et
al
fowler
et
al
wang
chang
hallmark
sever
case
sar
includ
high
viral
titer
system
infect
lymphopenia
overproduct
proinflammatori
cytokineschemokin
often
refer
cytokin
storm
wong
et
al
huang
et
al
cameron
et
al
howev
subsequ
consensu
regard
treatment
benefit
sar
patient
outbreak
stockman
et
al
develop
effect
treatment
strategi
sar
case
requir
clarifi
precis
mechan
host
immun
respons
control
sarscov
infect
cumul
evid
suggest
patient
recov
sar
possess
specif
acquir
immun
base
b
cell
yang
et
al
yang
et
al
li
et
al
fan
et
al
howev
effector
cell
molecul
act
elimin
sarscov
acut
phase
infect
remain
unclear
extens
outbreak
sar
recur
sinc
mechan
sarscov
infect
caus
pathogenesi
host
immun
respons
investig
use
adequ
anim
infecti
model
robert
et
al
nagata
et
al
zhao
et
al
zhao
perlman
lethal
diseas
balbc
mice
infect
mouseadapt
strain
sarscov
show
lack
activ
innat
immun
respons
result
bare
detect
antiviru
cell
respons
zhao
et
al
hand
age
balbc
mice
infect
human
clinic
isol
sarscov
urbani
strain
success
elimin
invas
viru
within
week
postinfect
mice
exhibit
high
prolong
level
viral
replic
sign
consist
clinic
symptom
patholog
chang
lung
resembl
seen
elderli
sar
patient
robert
et
al
therefor
infect
age
mice
consid
model
success
elimin
sarscov
host
immun
respons
recent
studi
report
cell
play
import
role
control
sarscov
infect
chen
et
al
research
also
report
import
role
innat
defens
mechan
control
sarscov
infect
demonstr
clearanc
sarscov
day
postinfect
dpi
balbc
mice
deplet
cell
chen
et
al
result
suggest
innat
adapt
immun
respons
essenti
control
sarscov
infect
nonetheless
ident
role
effector
cell
molecul
particip
elimin
sarscov
acut
phase
sar
remain
larg
unknown
studi
attempt
identifi
type
immun
cell
contribut
clear
sarscov
acut
phase
infect
work
employ
sever
murin
model
host
defici
eg
deplet
via
specif
antibodi
lack
via
immunodefici
supplement
eg
adopt
transfer
individu
immunolog
effector
demonstr
phagocyt
cell
includ
monocytederiv
infiltr
macrophag
partial
alveolar
macrophag
play
import
role
elimin
sarscov
mous
model
infect
adapt
immun
respons
essenti
elimin
pulmonaryinfect
sarscov
first
step
confirm
time
cours
viral
titer
lung
age
month
old
balbc
mice
young
week
old
balbc
mice
young
week
old
scid
mice
follow
infect
sarscov
intranas
infect
age
balbc
mice
sarscov
result
median
tissu
cultur
infecti
dose
tcid
g
lung
tissu
dpi
fig
infect
mice
exhibit
histolog
sign
sever
pneumonia
includ
interstiti
cell
thicken
immun
cell
infiltr
epitheli
damag
bronchu
dpi
dpi
fig
c
result
similar
previou
report
use
anoth
sarscov
strain
urbani
strain
robert
et
al
present
work
sarscov
detect
age
mice
start
earli
dpi
fig
observ
titer
agedmous
model
consider
higher
seen
infect
young
balbc
mice
show
appar
histolog
sign
pneumonia
fig
titer
age
mice
remain
high
tcid
g
lung
tissu
dpi
fig
howev
titer
decreas
level
lower
limit
detect
llod
tcid
g
lung
tissu
lung
age
balbc
mice
young
balbc
mice
dpi
fig
contrast
young
scid
mice
lack
function
b
cell
persist
infect
sarscov
experiment
period
dpi
shown
fig
time
scid
mice
exhibit
histolog
sign
sever
pneumonia
dpi
although
high
viral
titer
detect
lung
anim
experiment
period
fig
g
h
c
recent
zhao
perlman
obtain
similar
result
suggest
mouseadapt
mutant
sarscov
viral
strain
persist
infect
knockout
mice
background
anim
also
lack
b
cell
popul
taken
togeth
result
suggest
pathogenesi
sar
correl
direct
cytopath
effect
sarscov
investig
effect
adapt
immun
respons
clearanc
pulmonaryinfect
sarscov
either
splenocyt
obtain
balbc
mice
sensit
splenocyt
obtain
sarscovinfect
dpi
balbc
mice
adopt
transplant
scid
mice
day
sarscov
infect
shown
fig
scid
mice
receiv
splenocyt
elimin
sarscov
lung
earli
balbc
mice
scid
mice
transplant
sarscovsensit
splenocyt
balbc
mice
elimin
sarscov
rapidli
mice
transplant
splenocyt
although
initi
pulmonari
viral
titer
effect
group
scid
mice
dpi
without
transfer
splenocyt
one
scid
mice
receiv
sensit
splenocyt
show
detect
lung
pulmonari
viral
titer
tcid
g
lung
dpi
titer
remain
anim
group
point
llod
scid
mice
transplant
sensitizedsplenocyt
deriv
age
balbc
mice
show
histolog
sign
sever
pneumonia
dpi
although
infiltr
immunocompet
cell
around
bronchiol
arrow
partial
observ
lung
group
fig
result
indic
induct
adapt
immun
respons
essenti
clearanc
pulmonaryinfect
sarscov
identifi
host
defens
involv
elimin
sarscov
lung
deplet
cell
andor
cell
balbc
mice
sarscov
infect
deplet
cell
cell
perform
intraven
iv
inject
respect
monoclon
antibodi
mab
control
experi
demonstr
inject
mab
produc
virtual
complet
deplet
correspond
cell
popul
fig
celldeplet
balbc
mice
celldoubledeplet
balbc
mice
fail
elimin
sarscovinfect
pulmonari
cell
dpi
fig
contrast
celldeplet
balbc
mice
larg
elimin
sarscovinfect
pulmonari
cell
dpi
fig
recent
chen
et
al
report
cell
neutral
antibodi
follow
antibodi
respons
play
import
role
elimin
sarscovinfect
pulmonari
cell
howev
remain
unclear
whether
elimin
viru
present
work
chen
et
al
reflect
direct
antivir
effect
cell
andor
b
cell
notabl
sever
report
demonstr
presenc
cell
cytotox
activ
persist
viral
infect
includ
infect
human
immunodefici
viru
human
cytomegaloviru
epsteinbarr
viru
appay
et
al
casazza
et
al
landai
et
al
furthermor
cellmedi
control
viru
b
celldefici
mice
mediat
interferongamma
christensen
et
al
present
work
found
sarscov
persist
infect
lung
nude
celldefici
mice
well
scid
mice
defici
cell
b
cell
without
induc
histolog
sign
pneumonia
fig
b
therefor
investig
use
either
two
model
whether
cell
could
directli
elimin
sarscov
via
secret
first
model
consist
adopt
transfer
day
sarscov
infect
cell
cellsmous
balbc
mice
nude
mice
scid
mice
scid
mice
receiv
cell
transfer
erad
sarscov
infect
dpi
fig
contrast
nude
mice
receiv
quantiti
cell
decreas
pulmonari
viral
titer
llod
dpi
fig
second
model
investig
effect
elimin
sarscov
use
mous
model
mice
scid
mice
receiv
splenocyt
defici
mice
control
sarscov
infect
well
wildtyp
mice
fig
result
demonstr
cell
essenti
cell
type
control
sarscov
infect
effect
cell
fraction
indirect
result
show
sarscov
infect
could
control
nude
mice
receiv
cell
celldeplet
balbc
mice
suggest
b
cell
implic
elimin
sarscov
far
multipl
studi
demonstr
prophylact
effect
neutral
antibodi
hematoxylin
eosin
stain
section
thick
age
balbc
mice
dpi
c
dpi
b
young
scid
mice
dpi
e
g
dpi
f
h
micrograph
origin
magnif
c
detect
virusinfect
cell
lung
dpi
sarscov
nucleocapsid
protein
brown
stain
origin
magnif
tempor
chang
pulmonari
viru
titer
follow
age
balbc
mice
green
untreat
scid
mice
blue
scid
mice
transplant
splenocyt
balbc
mice
yellow
scid
mice
transplant
splenocyt
sensit
balbc
mice
red
splenocyt
cell
administ
intraven
recipi
scid
mous
day
infect
data
present
mean
sd
n
point
n
p
compar
splenocytetranspl
scid
mice
dpi
group
dpi
e
repres
lung
section
hematoxylin
eosin
stain
section
thick
group
dpi
spl
splenocyt
micrograph
origin
magnif
f
flow
cytometri
analysi
express
lymphocyt
isol
spleen
day
administr
indic
mab
g
viru
titer
lung
untreat
white
celldeplet
light
gray
celldeplet
dark
gray
celldeplet
balbc
mice
black
dpi
limit
detect
tcid
g
lung
data
present
mean
sd
n
point
sarscov
anim
model
casazza
et
al
landai
et
al
christensen
et
al
nichol
et
al
lee
et
al
peiri
et
al
furthermor
examin
whether
b
cell
play
import
role
elimin
sarscov
lung
use
scid
mice
transplant
b
cell
balbc
mice
infect
viru
although
celltranspl
scid
mice
cell
puriti
decreas
pulmonari
sarscov
titer
dpi
scid
mice
receiv
combin
cell
fraction
cell
subset
residu
cell
subset
subset
contain
cell
exhibit
mark
decreas
pulmonari
sarscov
titer
less
tcid
g
lung
tissu
fig
scid
mice
receiv
residu
cell
subset
alon
ie
fraction
also
exhibit
decreas
pulmonari
sarscov
titer
dpi
fig
examin
whether
postinfect
treatment
antisarscov
ab
could
control
sarscov
infect
scid
mice
infect
n
sarscov
administ
intraperiton
ip
twice
ml
rabbit
antispik
protein
antiserum
neutral
titer
nt
sarscov
rais
sarscov
protein
express
via
recombin
vaccinia
viru
kitabatak
et
al
yasui
et
al
group
treat
anti
protein
antiserum
elimin
sarscov
infect
neither
control
group
treat
normal
rabbit
serum
rabbit
antiserum
rais
nonrecombin
vaccinia
viru
elimin
sarscov
infect
fig
decreas
pulmonaryinfect
sarscov
titer
anti
protein
antiserumtr
scid
mice
confirm
quantit
rtpcr
detect
mrna
nucleocapsid
n
proteinencod
gene
sarscov
fig
result
suggest
product
antisarscov
ab
b
cell
celldepend
process
play
import
role
control
sarscov
infect
multipl
studi
demonstr
neutral
ab
import
humor
factor
control
viral
infect
shown
fig
administr
highdos
neutral
ab
nt
ml
dose
elimin
sarscov
although
antisera
use
deriv
anim
speci
howev
balbc
mice
erad
sarscov
infect
dpi
neutral
titer
antiserum
balbc
mice
achiev
nt
yasui
et
al
investig
whether
neutral
activ
ab
crucial
control
sarscov
infect
sarscovinfect
scid
mice
administ
ip
dpi
lower
dose
either
mous
antisarscov
antiserum
rabbit
anti
protein
antiserum
experi
neutral
titer
mous
antisarscov
antiserum
rabbit
balbc
mice
dpi
dpi
b
young
nude
mice
dpi
c
dpi
micrograph
origin
magnif
c
viru
titer
lung
celltranspl
scid
mice
determin
dpi
data
present
mean
point
cell
cell
administ
recipi
scid
mous
intraven
day
challeng
viru
titer
lung
nude
mice
adopt
transplant
cell
gray
residu
cell
cell
black
determin
dpi
untreat
nude
mice
white
includ
control
cell
cell
residu
cell
cell
administ
recipi
nude
mous
intraven
day
challeng
data
present
mean
sd
n
point
e
pulmonari
viru
titer
defici
mice
splenocytetranspl
scid
mice
dpi
splenocyt
cell
deriv
defici
mice
administ
recipi
scid
mous
intraven
day
challeng
data
present
mean
sd
point
nd
detect
spl
splenocyt
anti
protein
antiserum
adjust
nt
mous
antisarscov
antiserum
also
test
nt
shown
fig
singl
inject
ml
iv
nt
mous
sarscov
antiserum
rabbit
anti
protein
antiserum
reduc
pulmonari
sarscov
titer
singl
inject
mous
antisarscov
antiserum
even
lower
neutral
titer
ml
nt
also
reduc
pulmonari
viru
titer
greater
compar
untreat
anim
importantli
scid
mice
treat
rabbit
anti
protein
antiserum
elimin
sarscov
dpi
although
antisera
scid
mice
treat
rabbit
antiserum
clearli
demonstr
neutral
activ
sarscov
fig
inconsist
vitro
neutral
activ
vivo
clearanc
pulmonari
sarscov
activ
rabbit
antiserum
suggest
effector
besid
antisarscov
ab
also
might
requir
control
sarscov
infect
identifi
effector
involv
elimin
sarscovinfect
pulmonari
cell
mous
model
test
contribut
sever
candid
effector
sarscovinfect
balbc
mice
deplet
first
candid
complement
inject
cobra
venom
factor
cvf
umous
dpi
despit
deplet
serum
balbc
mice
follow
cvf
inject
fig
cvftreat
balbc
mice
still
elimin
sarscov
dpi
fig
result
demonstr
complementantibodi
complex
requir
control
sarscov
infect
model
next
investig
contribut
nk
cell
elimin
sarscov
administ
mab
treatment
known
result
longterm
deplet
nk
cell
tanaka
et
al
inject
ip
ml
ascit
scid
balbc
mice
three
day
treatment
nk
celldeplet
balbc
mice
splenocyt
transfer
adopt
nk
celldeplet
scid
mice
scid
mice
infect
sarscov
day
splenocyt
transfer
shown
fig
nk
cell
consider
deplet
donor
balbc
mice
spleen
recipi
scid
mice
howev
viru
still
erad
nkdeplet
model
fig
thu
abdepend
cellmedi
cytotox
requir
nk
cell
exclud
mechan
elimin
sarscov
blood
cell
also
may
serv
effector
control
sarscov
specif
elev
level
alveolar
macrophag
monocytederiv
infiltr
macrophag
neutrophil
observ
mani
sar
patient
nichol
et
al
lee
et
al
three
cell
type
implic
sar
patholog
role
cell
subset
control
sarscov
infect
still
unknown
investig
role
myeloid
cell
clearanc
sarscovinfect
pulmonari
tissu
subset
myeloid
cell
deplet
administr
specif
mab
reagent
consist
previou
report
pribul
et
al
alveolar
macrophag
deplet
day
follow
administr
clodron
liposom
fig
note
use
clodron
liposom
therebi
avoid
intens
infiltr
neutrophil
seen
administr
clodron
liposom
fig
neutrophil
hi
int
monocyt
blood
lung
significantli
deplet
least
day
ip
treatment
mab
wherea
neutrophil
alon
deplet
upon
administr
mab
fig
daley
et
al
cellandor
alveolar
macrophagedeplet
group
fail
elimin
pulmonari
sarscov
infect
fig
wherea
alveolar
macrophagedeplet
group
show
partial
elimin
viru
contrast
neutrophildeplet
balbc
anim
mabtreat
mice
elimin
sarscov
dpi
fig
importantli
neutral
ab
titer
celldeplet
mice
compar
untreat
balbc
mice
fig
p
similar
result
obtain
murin
antisarscov
antiseratr
scid
mice
administ
clodron
liposom
andor
mab
fig
result
suggest
phagocyt
cell
especi
monocytederiv
infiltr
macrophag
cooper
antisarscov
ab
provid
control
sarscov
infect
mous
model
outbreak
sar
result
case
mortal
worst
symptom
might
correl
agedepend
defect
immun
respons
given
mortal
exceed
patient
year
age
peiri
et
al
recent
studi
use
mous
model
suggest
agedepend
increas
prostaglandin
express
lung
may
associ
impair
immun
respons
zhao
et
al
retrospect
analys
recov
sar
patient
suggest
patient
recov
sar
possess
specif
acquir
immun
base
b
cell
yang
et
al
yang
et
al
li
et
al
fan
et
al
notabl
patient
recov
sar
elev
sustain
level
neutral
ab
patient
longer
ill
exhibit
lower
level
neutral
ab
patient
shorter
durat
ill
temperton
et
al
ho
et
al
previou
studi
reveal
passiv
transfer
immun
serum
anim
prevent
sarscov
replic
lower
respiratori
tract
yang
et
al
subbarao
et
al
kam
et
al
zhu
et
al
rockx
et
al
rockx
et
al
taken
togeth
result
suggest
ab
respons
like
play
import
role
determin
ultim
diseas
outcom
sarscov
infect
viru
could
erad
direct
bind
viru
neutral
ab
andor
cooper
virusspecif
ab
effector
cell
includ
complement
nk
cell
phagocyt
cell
howev
actual
mechan
control
acut
phase
sarscov
infect
remain
unclear
studi
found
rabbit
antiserum
rais
protein
sarscov
exhibit
significantli
lower
efficaci
control
viru
infect
mous
antisarscov
antiserum
similar
neutral
titer
sarscov
transfer
recipi
mice
therefor
appear
neutral
activ
ab
sarscov
correl
clearanc
efficaci
viru
infect
murin
lung
hand
antibodi
properti
avid
may
differ
murin
rabbit
antisera
given
former
polyclon
speci
deriv
sarscovinfect
mice
latter
gener
rabbit
protein
studi
need
resolv
distinct
chines
hamster
model
sar
postinfect
treatment
dpi
mgkg
equin
neutral
f
ab
result
partial
reduct
pulmonari
viral
titer
although
prophylact
treatment
lower
dose
suffici
complet
block
sarscov
infect
luo
et
al
result
suggest
antiinfect
activ
neutral
ab
mediat
primarili
via
prevent
sarscov
invas
neutral
ab
play
lesser
role
elimin
viru
establish
infect
therefor
focus
cooper
antisarscov
ab
effector
control
sarscov
infect
candid
effector
includ
complement
eg
member
complementantibodi
complex
pathway
nk
cell
mediat
abdepend
cellmedi
cytotox
pathway
fc
gamma
receptor
bear
cell
notabl
alveolar
macrophag
monocyt
monocytesderiv
infiltr
macrophag
neutrophil
previou
studi
report
mab
recogn
neutrophil
also
addit
leukocyt
popul
includ
monocyt
daley
et
al
therefor
use
mab
neutrophilspecif
mab
mab
discrimin
monocyt
neutrophil
test
role
candid
select
deplet
mous
infect
model
variou
factor
use
cvf
complement
deplet
mab
nk
cell
deplet
clodron
liposom
alveolar
macrophag
deplet
mab
monocytesneutrophil
deplet
mab
neutrophil
deplet
sarscov
infect
notabl
group
administ
clodron
liposom
mab
treat
mab
fail
elimin
sarscov
lung
dpi
result
indic
phagocyt
cell
monocytederiv
infiltr
macrophag
partial
alveolar
macrophag
neutrophil
play
crucial
role
elimin
sarscovinfect
pulmonari
cell
mice
although
littl
known
b
deplet
neutrophil
monocyt
monoclon
antibodi
mab
mab
respect
panel
show
result
flow
cytometr
analysi
express
leukocyt
blood
lung
balbc
mice
day
administr
mab
mab
untreat
balbc
use
control
repres
diagram
shown
c
pulmonari
viru
titer
balbc
mice
administ
mab
deplet
neutrophil
clodron
liposom
deplet
alveolar
macrophag
gray
mab
deplet
cell
dark
gray
clodron
liposom
mab
black
determin
dpi
data
present
mean
sd
n
nd
detect
cl
clodron
liposom
neutral
titer
sarscov
antisera
sarscovinfect
mice
dpi
e
pulmonari
viru
titer
passiv
immun
scid
mice
ie
inject
antisarscov
antiserum
administ
clodron
liposom
cl
deplet
alveolar
macrophag
gray
mab
deplet
cell
dark
gray
cl
mab
black
determin
dpi
data
present
mean
sd
nd
detect
host
defens
mechan
acut
phase
sar
clinic
infect
infiltr
larg
number
macrophag
lung
sar
patient
observ
nichol
et
al
frank
et
al
report
consist
result
although
studi
necessari
clarifi
mechan
elimin
sarscov
via
cooper
phagocyt
cell
sarscovspecif
antibodi
previou
studi
chen
et
al
result
fig
show
deplet
cell
time
infect
littl
effect
viral
replic
clearanc
zhao
perlman
report
adapt
transfer
cell
sensit
sarscov
strain
balbc
mice
complet
protect
recipi
subsequ
challeng
lethal
dose
zhao
et
al
also
show
diminish
virusspecif
cell
respons
result
ineffici
activ
alveolar
macrophag
respiratori
dendrit
cell
lethal
diseas
zhao
et
al
zhao
et
al
zhao
perlman
studi
also
demonstr
suboptim
respons
cell
respons
well
cell
impli
critic
role
antibodi
respons
infect
model
addit
deplet
alveolar
macrophag
infect
complet
protect
mice
lethal
challeng
deplet
alveolar
macrophag
day
infect
appear
exacerb
mortal
zhao
et
al
therefor
find
would
render
persuas
inclus
addit
anim
infect
experi
use
patient
isol
urbani
strain
mouseadapt
strain
sarscov
although
import
effector
cell
clearanc
coronavirus
still
unknown
sever
report
show
implic
cell
clearanc
influenza
viru
fujisawa
note
neutrophil
play
crucial
role
control
influenza
viru
infect
cooper
antiinfluenza
viru
antibodi
also
report
mice
highli
suscept
influenza
viru
infect
even
presenc
antiinfluenza
ab
immun
mice
huber
et
al
result
indic
import
role
effector
cell
clearanc
influenza
viru
infect
addit
demonstr
monocytederiv
macrophag
infiltratingtyp
partial
alveolar
macrophag
residenttyp
contribut
elimin
sarscovinfect
pulmonari
cell
presenc
antisarscov
ab
alveolar
macrophag
play
central
role
maintain
lung
homeostasi
consid
first
line
host
defens
respiratori
microb
mark
enhanc
viru
titer
report
respiratori
viru
infect
model
pribul
et
al
tumpey
et
al
hand
monocyt
circul
throughout
bodi
anticip
inflamm
infect
murin
monocyt
report
compris
two
distinct
subpopul
differ
phenotyp
lo
hi
monocyt
geissmann
et
al
infiltr
infect
site
inflammatori
monocyt
give
rise
variou
dendrit
cell
macrophag
type
varol
et
al
iijima
et
al
demonstr
monocytederiv
apc
requir
elicit
secret
effector
cell
thu
mediat
host
protect
infect
lin
et
al
report
monocytederiv
dc
macrophag
caus
immun
patholog
rather
viral
clearanc
influenza
viru
infect
contrast
monocytederiv
cell
involv
clearanc
sarscov
infect
although
role
monocytederiv
cell
develop
pathogenesi
sarscov
infect
remain
unknown
conclus
demonstr
crucial
role
cooper
antigenspecif
antibodi
phagocyt
cell
monocytederiv
infiltr
macrophag
partial
alveolar
macrophag
elimin
sarscov
mous
model
infect
find
provid
better
understand
mechan
host
defens
control
sarscov
infect
ideal
inform
contribut
develop
novel
therapeut
protocol
treatment
sar
studi
use
sarscov
strain
strain
origin
isol
singl
patient
throat
lavag
kindli
provid
dr
mai
quynh
le
hong
et
al
subcultur
vero
cell
grown
mem
nissui
pharmaceut
co
ltd
tokyo
japan
contain
fc
work
use
sarscov
perform
biosafeti
level
facil
personnel
wear
power
airpurifi
respir
shigematsu
co
ltd
tokyo
japan
scid
mice
femal
week
old
purchas
clea
japan
inc
tokyo
japan
balbc
mice
femal
month
old
week
old
nude
mice
femal
week
old
purchas
slc
shizuoka
japan
defici
mous
balbc
background
kind
gift
prof
iwakura
institut
medic
scienc
univers
tokyo
tokyo
univers
scienc
studi
day
mice
inocul
sarscov
tcid
per
mous
serial
time
point
mice
sacrif
anesthesia
follow
termin
blood
collect
lung
recov
portion
tissu
frozen
immedi
fix
buffer
formalin
blood
use
vitro
neutral
assay
adopt
transfer
experi
anim
experi
use
mice
approv
anim
experi
committe
institut
medic
scienc
univers
tokyo
perform
accord
anim
experiment
guidelin
institut
medic
scienc
univers
tokyo
confirm
deplet
efficaci
mab
ml
ascit
mab
ml
ascit
balbc
mice
inject
iv
indic
dose
volum
day
administr
respect
mab
spleenderiv
lymphocyt
analyz
flow
cytometri
express
test
efficaci
sarscov
infect
mab
andor
mab
inject
iv
day
respect
sarscov
challeng
experi
examin
deplet
cell
mab
mg
rat
inject
ip
day
sarscov
challeng
fujisawa
hybridoma
obtain
cell
resourc
center
biomed
research
institut
develop
age
cancer
tohoku
univers
miyagi
japan
mab
use
deplet
nk
cell
tanaka
et
al
kind
gift
prof
miyasaka
osaka
univers
japan
ml
ascit
inject
ip
day
adopt
transfer
balb
c
mice
splenocyt
scid
balbc
mice
mab
mg
rat
purchas
bioxcel
co
ltd
inject
ip
day
sarscov
challeng
deplet
cell
neutrophil
daley
et
al
deplet
respect
immunocompet
cell
confirm
flow
cytometr
analysi
one
hundr
microlit
clodron
liposom
suspens
inject
mice
day
sarscov
challeng
deplet
alveolar
macrophag
pribul
et
al
number
am
quantifi
bronchoalveolar
lavag
fluid
balf
deplet
complement
cobra
venom
factor
cvf
umous
gift
profokada
nagoya
citi
univers
japan
inject
ip
scid
mice
day
sarscov
challeng
pleyer
et
al
splenocyt
isol
sarscovinfect
dpi
sensit
balbc
mice
month
old
result
cell
administ
cellsanim
recipi
scid
mous
iv
day
challeng
splenocyt
nk
celldeplet
balbc
mice
also
administ
recipi
nk
celldeplet
scid
mice
describ
cell
cell
isol
spleen
balbc
mice
use
magnet
bead
follow
purif
automac
sorter
miltenyi
biotech
bergisch
gladbach
germani
isol
cell
puriti
adopt
transplant
recipi
scid
nude
mous
addit
splenocyt
balbc
mice
divid
cell
b
cell
residu
cell
cell
includ
cell
use
magnet
bead
miltenyi
biotech
b
cell
cell
cellsmous
andor
residu
cell
cell
cellsmous
adopt
transplant
recipi
scid
mice
previou
studi
new
zealand
white
rabbit
immun
recombin
vaccinia
viru
strain
express
gene
protein
sarscov
kitabatak
et
al
result
antisera
rabbit
anti
protein
show
high
neutral
activ
sarscov
nt
neg
control
rabbit
anti
antiserum
use
normal
rabbit
serum
andor
rabbit
antiserum
vaccinia
viru
strain
mous
antisarscov
antiserum
obtain
balbc
mice
day
sarscov
infect
point
antiserum
exhibit
nt
passiv
transfer
recipi
mous
receiv
ml
rabbit
anti
protein
antiserum
mous
antisarscov
antiserum
administ
iv
dpi
dpi
sarscov
titer
murin
lung
determin
describ
previous
yasui
et
al
briefli
lung
tissu
sampl
homogen
volum
leibovitz
medium
invitrogen
ca
usa
homogen
centrifug
g
min
supernat
collect
store
use
serial
dilut
supernat
ad
vero
cell
seed
plate
day
incub
cell
fix
buffer
formalin
viral
titer
determin
endpoint
dilut
homogen
induc
cytopath
effect
express
tcid
per
gram
tissu
method
use
endpoint
calcul
describ
reed
muench
serial
dilut
heatinactiv
sera
mix
equal
volum
tcid
sarscov
incub
h
vero
cell
infect
ml
virusserum
mixtur
plate
day
incub
neutral
titer
determin
endpoint
dilut
serum
inhibit
sarscovinduc
cytopath
effect
method
use
endpoint
calcul
describ
reed
muench
accord
previou
report
formalinfix
lung
tissu
sarscovinfect
mice
embed
paraffin
yasui
et
al
paraffin
block
section
thick
stain
hematoxylin
eosin
antigen
retriev
perform
autoclav
section
mm
citrat
buffer
ph
min
section
immers
hydrogen
peroxid
h
room
temperatur
rt
min
inactiv
endogen
peroxidas
section
block
skim
milk
trisbuff
salin
contain
rt
min
incub
overnight
mgml
antin
protein
sarscov
polyclon
antibodi
pab
imgenex
san
diego
ca
usa
secondari
label
perform
incub
rt
h
donkey
antirabbit
igg
ge
healthcar
buckinghamshir
uk
follow
color
develop
mm
trishcl
ph
min
nuclear
stain
perform
hematoxylin
solut
slide
imag
use
axio
imag
microscop
carl
zeiss
inc
oberkochen
germani
total
rna
sampl
extract
lung
use
illustra
rnaspin
midi
isol
kit
ge
healthcar
accord
manufactur
instruct
messeng
rna
level
n
proteinencod
gene
sarscov
measur
use
taqman
ez
rtpct
kit
appli
biosystem
branchburg
nj
usa
ml
reaction
mixtur
contain
ml
taqman
ez
buffer
ml
mm
mn
oac
ml
uml
amperas
ung
uracil
nglycosylas
ml
uml
rtth
dna
polymeras
ml
dntp
mix
mm
datp
mm
dctp
mm
dgtp
mm
dutp
ml
mm
probe
ml
mm
forward
revers
primer
ml
nucleasefre
water
ml
nucleic
acid
extract
amplif
carri
plate
abi
prism
sequenc
detect
system
softwar
ver
thermocycl
condit
consist
min
ung
treatment
min
revers
transcript
min
deactiv
ung
cycl
min
amplif
run
includ
pefmychissarsn
plasmid
ml
provid
standard
curv
least
one
notempl
control
primer
probe
use
studi
follow
forward
primer
revers
primer
probe
fam
ccacattggcacccgcaatcc
tamra
deplet
complement
quantifi
enzymelink
immunosorb
assay
elisa
mous
complement
kamiya
biomed
compani
seattl
wa
usa
data
present
mean
deviat
sd
applic
inferenti
statist
analysi
perform
oneway
anova
follow
tukey
test
nonparametr
analysi
perform
use
kruskalw
test
follow
mannwhitney
u
test
p
valu
consid
statist
signific
statist
calcul
perform
spss
statist
softwar
spss
inc
chicago
il
usa
